scholarly journals Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need

2019 ◽  
Vol 28 (3) ◽  
pp. 543-557 ◽  
Author(s):  
Soo Jung Hong ◽  
Barbara Biesecker ◽  
Jennifer Ivanovich ◽  
Melody Goodman ◽  
Kimberly A. Kaphingst
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Genetic Risk ◽  
Risk Information ◽  
Breast Cancer Patients ◽  
Information Need ◽  
Factors Affecting ◽  
Genetic Risk Information

scholarly journals Evaluation of breast cancer patients with genetic risk: Before and after a multidisciplinary heredofamiliar cancer unit implementation

2016 ◽  
Vol 27 ◽  
pp. vi465
Author(s):  
M. Lobo ◽  
S. Lopez-Tarruella ◽  
S. Luque ◽  
S. Lizarraga ◽  
P. Rincon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Genetic Risk ◽  
Breast Cancer Patients ◽  
Before And After

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit

2017 ◽  
Vol 27 (4) ◽  
pp. 854-862 ◽  
Author(s):  
Miriam Lobo ◽  
Sara López-Tarruella ◽  
Soledad Luque ◽  
Santiago Lizarraga ◽  
Carmen Flores-Sánchez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Genetic Risk ◽  
University Hospital ◽  
Breast Cancer Patients ◽  
Before And After

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients

2015 ◽  
Vol 152 (1) ◽  
pp. 67-76 ◽  
Author(s):  
Christof Vulsteke ◽  
Alena M. Pfeil ◽  
Charlotte Maggen ◽  
Matthias Schwenkglenks ◽  
Ruth Pettengell ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Genetic Risk ◽  
Cardiac Toxicity ◽  
Genetic Risk Factors ◽  
Breast Cancer Patients

Factors affecting lymphovascular invasion in node-positive breast cancer patients.

2011 ◽  
Vol 29 (27_suppl) ◽  
pp. 24-24
Author(s):  
L. B. Cornwell ◽  
K. McMasters ◽  
A. B. Chagpar
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Lymph Node Status ◽  
Breast Cancer Patients ◽  
Extracapsular Extension ◽  
Community Size ◽  
Factors Affecting ◽  
Younger Age ◽  
Clinicopathologic Factors ◽  
Pathology Reports

24 Background: Lymphatic and/or vascular invasion (LVI) is not uniformly reported in breast cancer tumors, and may be absent even in LN+ patients. The purpose of this study was to define factors associated with (a) the non-reporting of LVI, and (b) the finding of no LVI in LN+ patients. Methods: Data from 400 LN+ patients from a cohort of patients in a prospective multicenter study were reviewed. Institutional and clinicopathologic factors correlating with the reporting and finding of LVI were assessed using non-parametric statistical analysis. Results: Of the 400 LN+ patients in this cohort, LVI was not reported in 98 (24.5%) patients. Of the remaining 302 patients, LVI was reported as negative in 147 (48.7%). LVI was more often reported in later years (84.9% in 2001-2004 vs. 67.9% in 1997-2000, p<0.001). The reporting of LVI did not vary significantly by region, teaching affiliation, community size, or the surgeon’s proportion of breast practice or number of cases. Further, reporting of LVI was not associated with surgery type, patient age, number of positive nodes, size of largest metastasis, nor extracapsular extension. LVI was, however, more frequently reported in larger tumors (median tumor size 2.0 cm vs. 1.8 cm, p=0.030). Despite the finding that LVI was more frequently reported in later years, the proportion of patients found to have LVI did not vary by year (53.3% in 2001-2004 vs. 49.3% in 1997-2000, p=0.565), region, teaching affiliation, community size, or surgeon practice. LVI positivity was associated with younger age (median age 53 vs. 60, p=0.001), larger tumors (median size 2.5 vs. 1.8 cm, p<0.001), more positive lymph nodes (median 2.5 vs. 1, p<0.001), more macrometastases (58.7% vs. 36.5%, p=0.002), and more extracapsular extension (70.3% vs. 46.0%, p=0.001). Conclusions: Reporting of LVI has improved in recent years, and while the rate of LVI positivity has not changed in LN+ patients, it remains associated with poor prognostic factors in this cohort. Therefore, reporting of LVI should be encouraged as a standard part of synoptic pathology reports for breast cancer patients, regardless of lymph node status.

The implementation of a multidisciplinary heredofamilial cancer unit to increase the referral and preventive surgeries of breast cancer patients with genetic risk in a university hospital.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e13031-e13031
Author(s):  
Miriam Lobo de Mena ◽  
Sara Lopez-Tarruella ◽  
Soledad Luque Molina ◽  
Santiago Lizarraga ◽  
Patricia Rincon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Genetic Risk ◽  
University Hospital ◽  
Breast Cancer Patients

scholarly journals Genetic Risk, Perceived Risk, and Cancer Worry in Daughters of Breast Cancer Patients

2010 ◽  
Vol 20 (2) ◽  
pp. 157-164 ◽  
Author(s):  
John M. Quillin ◽  
Joann N. Bodurtha ◽  
Donna McClish ◽  
Diane Baer Wilson
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Genetic Risk ◽  
Perceived Risk ◽  
Breast Cancer Patients ◽  
Cancer Worry
Sign in / Sign up

Export Citation Format

Share Document